Fund Holdings — ACORN CAPITAL ADVISORS, LLC

Total Portfolio Value:
$366.46M
Total Bought:
$33.36M
Total Sold:
$103.34M
Net Transaction:
-$69.98M
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
CG Oncology, Inc.(CGON)1,130,5011,131,500+999$76.58M$80.39M21.94%+$3.81M
UroGen Pharma Ltd.(URGN)1,673,4201,673,4200$30.09M$61.58M16.80%+$31.49M
Trevi Therapeutics, Inc.(TRVI)2,144,8442,144,8440$25.59M$40.00M10.92%+$14.41M
Candel Therapeutics, Inc.(CADL)3,497,9483,497,9480$17.21M$36.03M9.83%+$18.82M
Puma Biotechnology, Inc.(PBYI)4,131,2994,131,2990$26.40M$33.50M9.14%+$7.11M
Jade Biosceinces Inc786,760986,760+200,000$11.05M$21.93M5.98%+$10.87M
Bicara Therapeutics643,382643,381-1$12.80M$19.10M5.21%+$6.31M
Karyopharm Therapeutics Inc.(KPTI)287,8261,518,113+1,230,287$1.60M$14.83M4.05%+$13.23M
OnKure Therapeutics, Inc.CL A(OKUR)2,839,6742,839,6740$11.76M$12.95M3.53%+$1.19M
Cybin D/B/A Helus Pharma(HELP)1,540,2661,540,2660$7.39M$10.18M2.78%+$2.79M
Protara Therapeutics, Inc.(TARA)1,752,1151,752,1150$9.13M$6.69M1.83%-$2.44M
Aura Biosciences, Inc.(AURA)595,744929,077+333,333$3.99M$6.60M1.80%+$2.61M
LeonaBio, Inc.(LONA)634,539634,5390$6.52M$5.83M1.59%-$691.6K
Verastem, Inc.(VSTM)1,469,1531,469,1530$7.79M$5.61M1.53%-$2.17M
Whitehawk Therapeutics, Inc.(WHWK)1,139,3631,139,3630$3.93M$5.22M1.42%+$1.29M
Q32 Bio Inc.(QTTB)315,052216,171-98,881$2.02M$2.75M0.75%+$731.4K
enGene Therapeutics Inc.(ENGN)01,271,257+1,271,257$0$2.20M0.60%+$2.20M
Jasper Therapeutics, Inc.(JSPR)1,411,4921,438,159+26,667$1.24M$604.0K0.16%-$638.1K
BioAtla, Inc.(BCAB)5,406,345108,126-5,298,219$865.0K$447.6K0.12%-$417.4K
Yarrow Bioscience Inc(YARW)1,4251,4250$855$9260.00%+$71
Cardiff Oncology, Inc.(CRDF)1,762,0840-1,762,084$2.85M$0—-$2.85M
Terns Pharmaceuticals Inc1,746,2640-1,746,264$92.06M$0—-$92.06M
X4 Pharmaceuticals, Inc.(XFOR)234,0390-234,039$966.6K$0—-$966.6K
Page 1 of 1